513 related articles for article (PubMed ID: 34757622)
1. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
[TBL] [Abstract][Full Text] [Related]
2. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
Erickson MA; Rhea EM; Knopp RC; Banks WA
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
[TBL] [Abstract][Full Text] [Related]
3. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
5. Nipah Virus Neurotropism: Insights into Blood-Brain Barrier Disruption.
Al-Obaidi MMJ; Muthanna A; Desa MNM
J Integr Neurosci; 2024 Apr; 23(5):90. PubMed ID: 38812392
[TBL] [Abstract][Full Text] [Related]
6. Zika virus crosses an in vitro human blood brain barrier model.
Alimonti JB; Ribecco-Lutkiewicz M; Sodja C; Jezierski A; Stanimirovic DB; Liu Q; Haqqani AS; Conlan W; Bani-Yaghoub M
Fluids Barriers CNS; 2018 May; 15(1):15. PubMed ID: 29759080
[TBL] [Abstract][Full Text] [Related]
7. The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis.
Coutard B; Romette JL; Miyauchi K; Charrel R; Prat CMA;
Biopreserv Biobank; 2020 Dec; 18(6):561-569. PubMed ID: 33181021
[TBL] [Abstract][Full Text] [Related]
8. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
Hachem M
Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
[TBL] [Abstract][Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
11. Astrocytes in the pathophysiology of neuroinfection.
Zorec R; Verkhratsky A
Essays Biochem; 2023 Mar; 67(1):131-145. PubMed ID: 36562155
[TBL] [Abstract][Full Text] [Related]
12. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
13. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.
Zhang L; Zhou L; Bao L; Liu J; Zhu H; Lv Q; Liu R; Chen W; Tong W; Wei Q; Xu Y; Deng W; Gao H; Xue J; Song Z; Yu P; Han Y; Zhang Y; Sun X; Yu X; Qin C
Signal Transduct Target Ther; 2021 Sep; 6(1):337. PubMed ID: 34489403
[TBL] [Abstract][Full Text] [Related]
15. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.
Kumar R; Harilal S; M S; Pappachan LK; P R R; Mathew B
Comb Chem High Throughput Screen; 2022; 25(5):763-767. PubMed ID: 34353250
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
Front Immunol; 2021; 12():697329. PubMed ID: 34386007
[TBL] [Abstract][Full Text] [Related]
17. The Neurobiology of Modern Viral Scourges: ZIKV and COVID-19.
Mittal S; Federman HG; Sievert D; Gleeson JG
Neuroscientist; 2022 Oct; 28(5):438-452. PubMed ID: 33874789
[TBL] [Abstract][Full Text] [Related]
18. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
[TBL] [Abstract][Full Text] [Related]
19. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
20. Computational and Experimental Approaches to Study the RNA Secondary Structures of RNA Viruses.
Yang SL; Ponti RD; Wan Y; Huber RG
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
